Skip to main content

Metabolic Syndrome clinical trials at UCSD

3 in progress, 2 open to eligible people

Showing trials for
  • C15:0 Supplementation in Young Adults at Risk for Metabolic Syndrome

    open to eligible people ages 18-25

    This study will determine changes in plasma C15:0 levels in young adults with BMI ≥ 25 in response to 12 weeks of daily oral C15:0 supplementation.

    La Jolla, California

  • The Influence of Time-Restricted Eating in Patients Metabolic Syndrome

    open to eligible people ages 18-75

    In a randomized controlled trial, the investigators intend to measure the health impact of TRE in patients with metabolic syndrome (with three or more of the following criteria: increased waist circumference, abnormal cholesterol levels, elevated blood pressure, or elevated blood sugar), who habitually eat for more than 14 hours every day. Patients will be randomly assigned to a control group of behavioral nutrition counseling (standard of care) or the intervention group of behavioral nutrition counseling with the addition of adopting a 10 hour eating window for 12 weeks (TRE).

    La Jolla, California

  • Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects

    Sorry, in progress, not accepting new patients

    Astaxanthin is a natural compound, present in many foodstuffs and available as a nutritional supplement that has been shown to have beneficial effects on many of the features of insulin resistance/glucose intolerance, at least in animals. The goal of this project is to provide a validation of astaxanthin effects on metabolic regulation in humans and their mechanism(s) of action, to determine if astaxanthin could have any value as a "neutraceutical" to help improve regulation of glucose and fat metabolism in subjects with insulin resistance/ glucose intolerance.

    San Diego, California

Last updated: